Min Zhang, Manman Li, Yangzan Ou, Qin Huang, Mingmin Leng, Xiangdong Yang et al. Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials. // BMC Gastroenterology. – 2025. – DOI: 10.1186/s12876-025-04065-w. – URL: https://doi.org/10.1186/s12876-025-04065-w
Min Zhang, Manman Li, Yangzan Ou, Qin Huang, Mingmin Leng, Xiangdong Yang, & Tao Yang (2025). Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-04065-w
Min Zhang, et al. “Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials.” BMC Gastroenterology, 2025. doi:10.1186/s12876-025-04065-w.
@article{Zhang2025,
title = {Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials},
author = {Zhang, Min and Li, Manman and Ou, Yangzan and Huang, Qin and Leng, Mingmin and Yang, Xiangdong and Yang, Tao},
journal = {BMC Gastroenterology},
year = {2025},
doi = {10.1186/s12876-025-04065-w},
url = {https://doi.org/10.1186/s12876-025-04065-w}
}